Dr. Thalia Field is a stroke neurologist and clinician-researcher with a focus on clinical trials. She is currently leading a national study examining the treatment and prognosis of cerebral venous thrombosis, a rare cause of stroke primarily affecting younger women. She has a particular interest in process improvement in clinical trials, including working with patients to identify important outcomes, and integrating existing and emergent technology to enhance efficiency and engage under-represented populations. She also investigates the impact of social determinants on brain health and has an outreach neurology clinic on Vancouver’s Downtown Eastside. Dr. Field is a Michael Smith Foundation for Health Research Health Professional-Investigator (2018) and holds a Sauder Family/Heart and Stroke Professorship of Stroke Research. In 2020, she was recognized as one of Canada’s Top 40 Under 40.